Id1: A novel therapeutic target for patients with atherosclerotic plaque rupture

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 627-628

  Wang, Guixue ^a   Qiu, Juhui ^a   Hu, Jianjun ^a   Tang, Chaojun ^a   Yin, Tieyin ^a  

^a CHONGQING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL POPULATION; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; HUMAN; HYPOXIA; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION; UPREGULATION;

ANOXIA; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MACROPHAGES; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; RUPTURE; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79954422510     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.014     Document Type: Article

References (25)

1. Shah P.K. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003, 41:15s-22s.
2. Bot I., de Jager S.C., Zernecke A., et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007, 115:2516-2525.
3. Sluimer J.C., Kolodgie F.D., Bijnens A.P., et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009, 53:1517-1527.
4. Kim H.J., Chung H., Yoo Y.G., et al. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res 2007, 5:321-329.
5. Maw M.K., Fujimoto J., Tamaya T. Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009, 9:430.
6. Ruzinova M.B., Schoer R.A., Gerald W., et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 2003, 4:277-289.
7. Nishiyama K., Takaji K., Kataoka K., et al. Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation 2005, 112:2840-2850.
8. Fung E., Tang S.M., Canner J.P., et al. Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Circulation 2007, 115:2948-2956.
9. Talora C., Campese A.F., Bellavia D., et al. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003, 4:1067-1072.
10. Moreno P.R., Purushothaman K.R., Fuster V., et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004, 110:2032-2038.
11. Khurana R., Simons M., Martin J.F., Zachary I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005, 112:1813-1824.
12. Ribatti D., Levi-Schaffer F., Kovanen P.T. Inflammatory angiogenesis in atherogenesis - a double-edged sword. Ann Med 2008, 40:606-621.
13. Sakurai D., Tsuchiya N., Yamaguchi A., et al. Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J Immunol 2004, 173:5801-5809.
14. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001, 7:425-429.
15. Lee T.K., Poon R.T., Yuen A.P., et al. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Clin Cancer Res 2006, 12:6910-6919.
16. Vendrov A.E., Madamanchi N.R., Hakim Z.S., Rojas M., Runge M.S. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res 2006, 98:1254-1263.
17. Tzeng S.F., Kahn M., Liva S., De Vellis J. Tumor necrosis factor-alpha regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury. Glia 1999, 26:139-152.
18. Gao D., Nolan D.J., Mellick A.S., Bambino K., McDonnell K., Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198.
19. Ciarrocchi A., Jankovic V., Shaked Y., et al. Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS One 2007, 2:e1338.
20. Nishiyama K., Takaji K., Uchijima Y., et al. Protein kinase A-regulated nucleocytoplasmic shuttling of Id1 during angiogenesis. J Biol Chem 2007, 282:17200-17209.
21. Volpert O.V., Pili R., Sikder H.A., et al. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2002, 2:473-483.
22. Doyle B., Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 2007, 49:2073-2080.
23. Abdollahi A., Hahnfeldt P., Maercker C., et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004, 13:649-663.
24. Cochrane S.W., Zhao Y., Welner R.S., Sun X.H. Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions. Blood 2009, 113:1016-1026.
25. Geest C.R., Buitenhuis M., Vellenga E., Coffer P.J. Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia. Haematologica 2009, 94:1075-1084.